Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEPress Release▲ PositiveM&A19h ago

Tata Motors Limited

Press Release

Tata Motors launches a recommended all-cash voluntary tender offer for IVECO Group Common shares at EUR 14.1 per share, with the Iveco Group Board of Directors supporting the transaction and Exor N.V. committing to support the offer with its 27.06% stake.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A1d ago

Oriental Rail Infrastructure Ltd

Press Release

Oriental Rail Infrastructure Ltd enters into a Technology Development Agreement with UWC's design & engineering arm to design and develop a 25-tonne axle-load bogie and a solid-bottom gondola car, strengthening its technology-led product development and advanced rolling stock capabilities.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A1d ago

Vikram Kamats Hospitality Ltd

Investor Presentation

Vikram Kamats Hospitality Ltd has submitted an investor presentation to the BSE, highlighting its company overview, management team, and presence in the hospitality industry. The presentation covers the company's history, key highlights, brands, and achievements during the review period. The company has been making profits since its listing for over 7 consecutive years, with a revenue CAGR of 145% since listing. It operates and grants licenses for its own and licensed brands, including Kamats, Kamats Legacy, and VITS. The company has also launched several premium outlets and has a strong presence in the hospitality industry.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A1d ago

AJC Jewel Manufacturers Ltd

Press release

AJC Jewel Manufacturers Ltd has announced the acquisition of an 80% stake in AJC Jewel Manufacturers (FZC), a UAE-based precious metal jewellery manufacturing company, for ₹9.60 crore through a non-cash share swap. The acquisition will consolidate the company's international operations and enable it to have greater ownership and control over the UAE business.

Read more →📎 1 attachment
BSEOthers▲ PositiveM&A2d ago

Cohance Lifesciences Ltd

Outcome of Committee Meeting

Cohance Lifesciences Ltd has announced two proposed transactions to strengthen its Antibody-drug Conjugate (ADC) strategy, investing USD 13 million in NJ Bio and USD 5 million in Aruka Bio, increasing its stake in NJ Bio from 56% to 67.3% and acquiring a controlling stake in Aruka Bio.

Read more →📎 1 attachment
NSECommittee Meeting Updates▲ PositiveM&A2d ago

Cohance Lifesciences Limited

Committee Meeting Updates

Cohance Lifesciences Limited has informed the Exchange regarding Outcome of Committee Meeting held on September 03, 2026, where the Investment, Banking and Authorisations Committee (IBA Committee) has approved the acquisition of additional shares in NJ Bio and a controlling investment in Aruka Bio to strengthen its Antibody-drug Conjugate (ADC) strategy.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A2d ago

RPG Life Sciences Ltd

Investors Presentation

RPG Life Sciences Ltd announces investors presentation, detailing subsidiary of API business into RPGAP for strategic focus, partnership with pharma-centric PE firm InvAscent, and acquisition of Actis Generics and Raghava Life Sciences for enhancing product portfolio and capacity.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveM&A2d ago

RPG Life Sciences Limited

Investor Presentation

RPG Life Sciences Limited has informed the Exchange about Investor Presentation, which includes details of its subsidiary RPG Active Pharma (RPGAP) acquiring Actis Generics and Raghava Life Sciences to enhance its product portfolio and capacity.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A2d ago

RPG Life Sciences Ltd

Press Release

RPG Life Sciences Ltd's wholly owned subsidiary, RPG Active Pharma Limited (RPGAP), has acquired the Active Pharmaceutical Ingredients (API) and Intermediates business undertaking of Raghava Life Sciences Private Limited for up to ₹135 crore. The acquisition is expected to strengthen RPGAP's integrated API play and capture a larger share of the growing API market.

Read more →📎 1 attachment
NSEPress Release▲ PositiveM&A2d ago

RPG Life Sciences Limited

Press Release

RPG Life Sciences Limited's wholly owned subsidiary, RPG Active Pharma Limited, has acquired the Active Pharmaceutical Ingredients (API) and Intermediates business undertaking of Raghava Life Sciences Private Limited for up to ₹135 crore. The acquisition strengthens RPG Active Pharma's integrated API play and adds approximately 300 KL of installed capacity in a state-of-the-art EU-GMP approved plant and a portfolio of 22 commercialized APIs plus 7 under development.

Read more →📎 1 attachment
NSEUpdates▲ PositiveM&A3d ago

Kirloskar Oil Engines Limited

Updates

Kirloskar Oil Engines Limited has entered into a strategic co-operation with DEUTZ on the 1.6-Litre Engine Platform, expanding its global reach and offering compact engine solutions in Europe and North America.

Read more →📎 1 attachment
NSEPress Release▲ PositiveM&A3d ago

MphasiS Limited

Press Release

Mphasis Limited has signed a strategic agreement with TechnoPro Holdings to accelerate AI-led enterprise transformation in Japan. The partnership will bring Mphasis' AI-powered enterprise offerings to the Japanese market, enabling organizations to modernize legacy environments and optimize business operations.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A3d ago

Mphasis Ltd

Intimation of Press Release

Mphasis Ltd, a global AI-led technology solutions provider, has signed a strategic agreement with TechnoPro Holdings, Japan's largest technology-focused engineering staffing and IT solutions provider, to bring Mphasis' AI-powered enterprise offerings to the Japanese market.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveM&A3d ago

eClerx Services Limited

Analysts/Institutional Investor Meet/Con. Call Updates

eClerx Services Limited has informed the Exchange about Presentation for eClerx Investor Day 2026, which includes a company overview, growth strategy, and financial performance for FY24-FY26. The presentation highlights the company's strengths, opportunities, and challenges, and outlines a three-pillar strategy for the next phase of growth.

Read more →📎 1 attachment
Page 1 of 23Next →